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Prinzmetal’s variant angina was reported more than half century
go in the USA [1]. Variant angina is characterized by a tran-
ient coronary luminal reduction accompanied with reversible ST
levation on electrocardiogram (ECG) with and without organic
tenosis. Until Yasue and Okumura et al. reported the usefulness
f selective acetylcholine testing in diagnosing patients with coro-
ary artery spasm, the majority of cardiologists in Japan performed
cetylcholine test due to selective method and short half-life of
cetylcholine [2,3]. However, fewer and fewer cardiologists per-
ormed spasm provocation tests in the cardiac catheterization
aboratory in accordance with the more widespread use of coronary
ntervention therapy. At least in North America, Prinzmetal’s vari-
nt angina has become less frequent for reasons that are unclear,
erhaps because of the more widespread use of calcium antago-
ists. We  also reported a decrease in variant angina in Japan due
o the widespread use of calcium channel blockers in 2003 [4].
acial differences concerning coronary artery spasm have been
eported [5,6], and coronary artery spasm in Japanese is three times
igher than in Caucasians. However, spasm provocation test is not
roadly applied on clinical grounds in the USA and Europe, as in
apan. Coronary artery spasm may  be involved in the genesis of
arious cardiac disorders, such as unstable angina, sudden cardiac
eath, syncope, transient heart failure, serious fatal arrhythmia,
nd atypical chest symptoms [7–9]. Coronary artery spasm also
auses acute coronary syndrome (ACS). In one study, the major-
ty of patients with ACS had culprit lesions and were selected for
rimary coronary intervention (PCI) or coronary artery bypass graft
CABG). Up to 70% of patients with ACS with typical ECG changes
nd/or elevation of cardiac markers had culprit lesions, whereas the
emaining 30% of ACS patients had no obstructive coronary artery
esions. Cardiologists in the USA do not perform spasm provocation
ests routinely in patients with non-obstructive coronary artery
isease with chest pain/discomfort in the cardiac catheterization
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ttp://dx.doi.org/10.1016/j.jccase.2012.08.006laboratory. However, in Europe, Da Costa et al. reported that 16%
of French patients with myocardial infarction and normal coro-
nary arteries had ergonovine-induced coronary spasm [10]. Ong
et al. also reported that almost half of German patients with ACS
and without culprit lesions who underwent the acetylcholine test
had proof of coronary artery spasm. Even in Caucasian patients in
Europe with ACS and without culprit lesions, coronary artery spasm
may  be present in 16–49% [11]. Investigation of spasm on clinical
grounds should also be examined in these patients with ACS and
without culprit lesions in the USA.
We found a positive relationship between the spasm provo-
cation test numbers and spasm positive numbers in a Japanese
questionnaire study of coronary artery spasm [12]. At least in Japan,
if spasm provocation tests were not performed, cardiologists did
not ﬁnd vasospastic angina any more. There were few patients
with vasospastic angina in hospitals where cardiologists were busy
performing PCI and had less time to spare performing spasm provo-
cation tests. Until now, coronary artery spasm might be missed due
to fewer procedures of spasm provocation tests in the USA. If spasm
provocation tests were performed routinely in the USA and Europe
on clinical grounds to clarify the mechanism of ischemic ﬁndings in
patients with non-obstructive coronary artery disease, Caucasians
may also notice like Japanese that coronary artery spasm is asso-
ciated with various cardiac disorders. Racial difference concerning
coronary artery spasm may  be lower than the past reports. More-
over, coronary artery spasm may  have no racial difference or no
racial border.
In  the case reported by Choksy et al., before performing PCI
in the right coronary artery, no intracoronary administration of
nitroglycerine was performed during the ﬁrst catheterization [13].
Coronary artery spasm was  not considered in the ﬁrst catheteriza-
tion, and the patient was discharged on numerous medications not
including calcium channel blocker and long-acting nitrate. Beta-
blocker might have attenuated his chest pain attacks whereas he
complained of having recurrent chest pain mostly in the morning
since the time of discharge. He remained symptom-free dur-
ing the follow-up period after starting on vasodilator therapy
with amlodipine and isosorbide mononitrate. Not beta-blocker
but calcium channel blocker/long-acting nitrate should have been
selected for this patient with ACS. Fortunately, coronary stent was
not inserted in this patient in the right coronary artery. Until
now, PCI including unnecessary implantation of coronary stents
sometimes might be performed in these ACS patients in the USA.
It is necessary to administer some amount of nitroglycerine into
the responsible vessel in patients with ACS during the emergency
vier Ltd. All rights reserved.
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ardiac catheterization to exclude the presence of coronary artery
pasm. In the USA and Europe, beta-blocker is the ﬁrst-line ther-
py in patients with ischemic heart disease. In contrast, calcium
hannel blocker is also often employed in patients with ischemic
eart disease in Japan [14]. If there was more widespread of
pasm provocation tests in USA and Europe to investigate the
schemic evidence in patients with coronary artery disease, not
nly beta-blockers but also calcium channel blockers may be neces-
ary for Caucasian patients with ischemic and non-ischemic heart
isease.
The Japanese Circulation Society established the guidelines for
iagnosis and treatment of patients with vasospastic angina in
008, thus being the ﬁrst in the world [15]. Until the guide-
ines had been established, the deﬁnition of positive spasm during
pasm provocation test was not the same at each hospital in
apan. Vasospastic angina is diagnosed in Japan using criteria
ndependently adopted by individual institutions. The principal
haracteristics of this guideline have the diagnostic ﬂow chart of
asospastic angina. It is most important point to diagnose vasospas-
ic angina patients with symptoms and using non-invasive tests
ather than without performing invasive spasm provocation test
ggressively. In this guideline, reference items based on Yasue’s
tatement are included in the diagnostic criteria established for
he grades: “deﬁnite”, “suspected”, or “unlikely”. The patient is
onsidered to have “deﬁnite” vasospastic angina when ischemic
hange (ST elevation or ST depression of 0.1 mV  or more) is clearly
bserved on the ECG during attacks or a positive ﬁnding of coronary
pasm on coronary angiography (>90% stenosis) by drug-induced
oronary spasm provocation test or hyperventilation test. We  diag-
osed “suspected” vasospastic angina when an angina-like attack
isappears quickly upon administration of a nitrate, and that meets
t least one of the following four items: (1) appears at rest, par-
icularly between night and early morning; (2) marked diurnal
ariation in exercise tolerance is observed; (3) induced by hyper-
entilation and (4) attacks are suppressed by calcium channel
lockers but not by beta-blockers. Clinically, both deﬁnite and sus-
ected vasospastic angina are diagnosed as vasospastic angina. In
his guideline, PCI in combination with adequate administration
f coronary dilators for vasospastic angina patients with severe
rganic stenosis is classiﬁed as Class IIa. And, PCI for vasospas-
ic angina patients without severe organic stenosis is classiﬁed
s Class III. PCI procedure in this patient has been demonstrated
o be useless and possibly harmful at times, or its harmfulness
as been widely agreed upon. In the USA, the recognition of
rinzmetal’s variant angina is low even by clinical cardiologists.
hus, we recommend the establishment of a guideline for vari-
nt angina and vasospastic angina in USA. Therefore, Caucasians in
he USA and Europe will recognize the presence of ST elevation in
rinzmetal’s variant angina. Moreover, we hope to establish world-
ide uniﬁed guidelines for diagnosis and treatment of patients with
rinzmetal’s variant angina and vasospastic angina in cooperation
ith the American Heart Association, American College of Cardi-
logy, European Society of Cardiology, and Japanese Circulation
ociety.ases 6 (2012) e161–e162
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